Florence Laigle-Donadey

Years Active: 2019-2021
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Didier Frappaz, Marc Barritault, Laure Montané, Florence Laigle-Donadey, Olivier Chinot, Emilie Le Rhun, Alice Bonneville-Levard, Andreas F Hottinger, David Meyronnet, Anne-Sophie Bidaux, Gwenaële Garin, David Pérol
MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation. Neuro-oncology 23 (11) (2021)
Florence Laigle-Donadey, François Ducray, Matthieu Boone, Mamadou Hassimiou Diallo, David Hajage, Carole Ramirez, Olivier Chinot, Damien Ricard, Jean-Yves Delattre
A phase III double-blind placebo-controlled randomized study of dexamphetamine sulfate for fatigue in primary brain tumors patients: An ANOCEF trial (DXA). Neuro-oncology advances 1 (1) (2019)

Florence Laigle-Donadey.css-eqlu8i{font-size:small;padding-left:4px;}